Barclays raised the firm’s price target on Clorox to $148 from $118 and keeps an Underweight rating on the shares. The analyst says Clorox’s guidance “feels exceedingly conservative.” As such, the firm models earnings 13% above the outlook.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CLX: